|
|
Microbial manufacturing development challenges experience three key difficulties. Researchers must develop a strain that maximizes expression. Fermentation development must maximize scale-up efficacy and limit process-related impurities. Midstream development must lead to high process yields that are consistently predictable. |
|
|
|
Choose a flexible and experienced CDMO to ensure scalability, diverse process capabilities, and expert analytical support for your microbial protein production—from early development through commercial manufacturing. The right partner will offer tailored upstream and downstream solutions, regulatory expertise, and robust quality systems. |
|
|
|
Drug developers must understand the latest trends in microbial fermentation. By leveraging innovative methods and technologies, developers can unlock new opportunities, improve patient outcomes, and make a significant impact. Stay ahead of the curve and ensure the success of your future microbial fermentation projects. |
|
|
|
A successful tech transfer sets the stage for GMP production and opens the door to process performance qualification campaigns and licensure. That success depends on prompt, accurate communication between the customer and the CDMO and transparency in communications regarding where problems may exist or could be anticipated. |
|
|
|
|
|
|
|
|
|
